Basilea Pharmaceutica AG (SWX:BSLN)
40.95
-1.75 (-4.10%)
Apr 4, 2025, 11:44 AM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 517.95 million as of April 4, 2025. Its market cap has increased by 21.21% in one year.
Market Cap
517.95M
Enterprise Value
508.91M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.33
Stock Price
40.95
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has decreased from 533.29M to 517.95M, a decrease of -2.88%. That is a compound annual growth rate of -0.14%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 229.85B |
Novartis AG | 183.72B |
Alcon | 40.45B |
Lonza Group AG | 38.42B |
Galderma Group AG | 22.29B |
Straumann Holding AG | 16.84B |
Sandoz Group AG | 15.60B |
Sonova Holding AG | 15.02B |